Best of Oncology East Conference 2025: Eli Lilly Breakfast Symposium: Shifting the Horizon: Long-Term Survival with CDK4/6i in HR+ HER2- high-risk early Breast Cancer – Dr. Christine Brezden-Masley

Explore more from your favourite experts – click their name to access their entire library of content.
This program has been made possible through unrestricted support from Eli Lilly